Shockwave Medical(@ShockwaveIVL):For International Audiences: Patients with diabetes often represent a more complex population, but REDUCER I showed that #ShockwaveReducer delivers angina relief equally for patients suffering from diabetes. The trial demonstrated that device implantation was safe and just as effective at improving angina symptoms and quality of life in patients with and without diabetes. Explore the REDUCER I Diabetes Sub-Analysis: https://t.co/3XDomSOlvc de Silva, R. Results from the REDUCER-I Study. ESC 2025 Safety Info: https://t.co/Hoe9Pz5DB2 CAUTION: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada.

2026.07.01 09:00

For International Audiences: Patients with diabetes often represent a more complex population, but REDUCER I showed that #ShockwaveReducer# delivers angina relief equally for patients suffering from diabetes. The trial demonstrated that device implantation was safe and just as effective at improving angina symptoms and quality of life in patients with and without diabetes. Explore the REDUCER I Diabetes Sub-Analysis: de Silva, R. Results from the REDUCER-I Study. ESC 2025 Safety Info: CAUTION: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada.